214 results on '"Porter, D. L."'
Search Results
2. Metallic Fuels Handbook
3. Higher tacrolimus concentrations early after transplant reduce the risk of acute GvHD in reduced-intensity allogeneic stem cell transplantation
4. CD33-specific chimeric antigen receptor T cells exhibit potent preclinical activity against human acute myeloid leukemia
5. Reduced-intensity conditioned allogeneic SCT in adults with AML
6. Fuel Performance Design Basis for the Versatile Test Reactor
7. The Impact of EBV Status on Characteristics and Outcomes of Posttransplantation Lymphoproliferative Disorder
8. Predictors of long‐term survival outcomes following receipt of autologous stem cell transplantation for patients with diffuse large/high grade B cell lymphoma.
9. High-dose corticosteroids with or without etanercept for the treatment of idiopathic pneumonia syndrome after allo-SCT
10. Allogeneic hematopoietic SCT for primary cutaneous T cell lymphomas
11. Inflammatory cytokine inhibition with combination daclizumab and infliximab for steroid-refractory acute GVHD
12. Stem cell collection in patients with multiple myeloma: impact of induction therapy and mobilization regimen
13. Second auto-SCT is safe and effective salvage therapy for relapsed multiple myeloma
14. Donor leukocyte infusions for the treatment of relapsed acute leukemia after allogeneic stem cell transplantation
15. The early characterization of irradiation effects in stainless steels at the Experimental Breeder Reactor-II
16. Prognostic value of FDG-PET scan imaging in lymphoma patients undergoing autologous stem cell transplantation
17. Void Swelling of Annealed 304 Stainless Steel at ∼ 370-385°C and PWR-Relevant Displacement Rates
18. Long-term event-free survivors after high-dose therapy and autologous stem-cell transplantation for low-grade follicular lymphoma
19. Intensive graft-versus-host disease prophylaxis is required after unrelated-donor nonmyeloablative stem cell transplantation
20. T-cell reconstitution and expansion after hematopoietic stem cell transplantation: ‘T’ it up!
21. ‘GVHD’: graft-versus-host disease or graft-versus-Hodgkin's disease? an old acronym with new meaning
22. Post-transplant lymphoproliferative disorder: a review
23. Association of HLA Polymorphisms with Post-transplant Lymphoproliferative Disorder in Solid-Organ Transplant Recipients
24. Reduction of Immunosuppression as Initial Therapy for Posttransplantation Lymphoproliferative Disorder
25. Donor leukocyte infusions in acute myelogenous leukemia
26. Peripheral CD34 Counts are Predictive of Outcome in Leukapheresis in Hodgkinʼs Disease and Non-Hodgkinʼs Lymphoma Patients
27. Comparison of Clinical Outcomes in Patients with Hodgkinʼs Disease, non-Hodgkinʼs Lymphoma, and Multiple Myeloma Undergoing Autologous Peripheral Stem Cell Transplants
28. Experimental studies of U-Pu-Zr fast reactor fuel pins in the experimental breeder reactor-ll
29. Fuel constituent redistribution during the early stages of U-Pu-Zr irradiation
30. Swelling behavior of U-Pu-Zr fuel
31. Nuclear energy plant optimization (NEPO) final scientific/technical report
32. Outcomes with bendamustine lymphodepletion and brexucabtagene autoleucel for mantle cell lymphoma.
33. Outcomes of diffuse large/high grade B cell lymphoma patients following receipt of autologous stem transplantation or chimeric antigen receptor‐modified T cells.
34. Higher tacrolimus concentrations early after transplant reduce the risk of acute GvHD in reduced-intensity allogeneic stem cell transplantation
35. Oogenesis and chromosomal heterozygosity in the thelytokous midge, Lundstroemia parthenogenetica (Diptera, Chironomidae)
36. BENDAMUSTINE LYMPHODEPLETION TRIGGERS REDUCED INFLAMMATORY CYTOKINES AND DECREASED TOXICITIES AFTER BOTH 4‐1BB‐ AND CD28‐COSTIMULATED CART19 FOR NON‐HODGKIN LYMPHOMA.
37. Measurement of Helium Generation in AISI 304 Reflector and Blanket Assemblies after Long-term Irradiation in EBR-II
38. Measurement of Helium Generation in AISI 304 Reflector and Blanket Assemblies after Long-term Irradiation in EBR-II
39. IBuoy: Expendable short time duration wave buoy with satellite data telemetry
40. Allogeneic hematopoietic SCT for primary cutaneous T cell lymphomas
41. Time from relapse after allogeneic stem cell transplantation (SCT) to donor leukocyte infusion (DLI) is longer, incidence of GVHD is higher, but survival is similar for recipients of unrelated DLI compared to matched sibling DLI.
42. Willie Mays: The Life, the Legend. By James S. Hirsch. (New York: Scribner, 2010. x, 628 pp. $30.00, ISBN 978-1-4165-4790-7.)
43. Inflammatory cytokine inhibition with combination daclizumab and infliximab for steroid-refractory acute GVHD
44. Meta-analysis of risk for lymphoma with immunomodulators for inflammatory bowel disease.
45. Stem cell collection in patients with multiple myeloma: impact of induction therapy and mobilization regimen
46. Second auto-SCT is safe and effective salvage therapy for relapsed multiple myeloma
47. Lenalidomide and stem cell collection in patients with multiple myeloma
48. Donor leukocyte infusions for the treatment of relapsed acute leukemia after allogeneic stem cell transplantation
49. Effect of rituximab (R) on clinical outcomes after autologous stem cell transplantation (ASCT) in pts with relapsed or refractory diffuse large B-cell lymphoma (DLBCL)
50. Outpatient autologous stem cell transplants for selected patients with myeloma: Morbidity, mortality, and duration of hospitalization
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.